Finance

Beta
Lists
PHN:BIT
Pharmanutra SpA
€91.70
+3.73%
(+3.30) 1D
Jun 3, 2:47:26 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHN...
Open
€85.30
High
€94.45
Low
€85.30
Mkt. cap
887.75M
Avg. vol.
13.84K
Volume
18.54K
Dividend
1.31%
Quarterly dividend
€0.30
Ex-dividend date
May 4, 2026
P/E ratio
41.75
52-wk high
€94.45
52-wk low
€38.75
EPS
€2.20
Shares outstanding
9.68M
No. of employees
140
Open
€85.30
High
€94.45
Low
€85.30
Mkt. cap
887.75M
Avg. vol.
13.84K
Volume
18.54K
Dividend
1.31%
Quarterly dividend
€0.30
Ex-dividend date
May 4, 2026
P/E ratio
41.75
52-wk high
€94.45
52-wk low
€38.75
EPS
€2.20
Shares outstanding
9.68M
No. of employees
140
News stories
From sources across the web
About Pharmanutra SpA
CEO-
Employees140
Founded2000
Headquarters-
SectorPersonal care products
Websitepharmanutra.it
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (EUR)
€0.36 / -
0.00%miss
Revenue / Est. (EUR)
33.40M / -
0.00%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
36.27M
31.86M
37.20M
33.40M
Cost of goods sold
7.05M
34.06M
19.19M
7.67M
Cost of revenue
7.05M
34.06M
19.19M
7.67M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.09M
-10.08M
9.22M
19.13M
Operating expense
18.88M
-9.26M
10.39M
20.47M
Total operating expenses
25.93M
24.80M
29.58M
28.13M
Operating income
10.35M
7.06M
7.62M
5.26M
Other non operating income
-
707.00K
937.00K
-
EBT including unusual items
10.37M
7.60M
8.17M
5.26M
EBT excluding unusual items
10.37M
7.60M
8.50M
5.26M
Income tax expense
3.63M
2.81M
2.19M
1.82M
Effective tax rate
35.05%
37.00%
26.83%
34.53%
Other operating expenses
616.00K
143.00K
303.00K
395.00K
Net income
6.75M
4.82M
5.99M
3.46M
Net profit margin
18.61%
15.14%
16.11%
10.35%
Earnings per share
-
-
-
-
Interest and investment income
474.00K
95.00K
134.00K
252.00K
Interest expense
-453.00K
-222.00K
-143.00K
-252.00K
Net interest expenses
21.00K
-127.00K
-9.00K
-
Depreciation and amortization charges
1.18M
671.00K
864.00K
947.00K
EBITDA
11.52M
7.53M
7.83M
6.21M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer